Clinical Trial: An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ovary Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer
Brief Summary:
The Principal Investigator hypothesizes the combination of MIRV and Olaparib is an effective, and tolerable, maintenance therapy strategy in platinum sensitive recurrent ovarian cancer.
Read more